Icosavax Balance Sheet Health

Financial Health criteria checks 6/6

Icosavax has a total shareholder equity of $232.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $251.3M and $18.9M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$229.21m
EquityUS$232.38m
Total liabilitiesUS$18.92m
Total assetsUS$251.30m

Recent financial health updates

Recent updates

We Think Icosavax (NASDAQ:ICVX) Can Afford To Drive Business Growth

Jul 04
We Think Icosavax (NASDAQ:ICVX) Can Afford To Drive Business Growth

Will Icosavax (NASDAQ:ICVX) Spend Its Cash Wisely?

Mar 10
Will Icosavax (NASDAQ:ICVX) Spend Its Cash Wisely?

Is Icosavax (NASDAQ:ICVX) In A Good Position To Invest In Growth?

Oct 18
Is Icosavax (NASDAQ:ICVX) In A Good Position To Invest In Growth?

Icosavax GAAP EPS of -$0.57

Aug 15

Icosavax to pursue COVID bivalent vaccine in 2023 as biotech highlights near-term milestones

Jul 28

Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

Jun 22
Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

Mar 24
Here's Why We're Not Too Worried About Icosavax's (NASDAQ:ICVX) Cash Burn Situation

We're Hopeful That Icosavax (NASDAQ:ICVX) Will Use Its Cash Wisely

Oct 29
We're Hopeful That Icosavax (NASDAQ:ICVX) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: ICVX's short term assets ($235.3M) exceed its short term liabilities ($13.0M).

Long Term Liabilities: ICVX's short term assets ($235.3M) exceed its long term liabilities ($5.9M).


Debt to Equity History and Analysis

Debt Level: ICVX is debt free.

Reducing Debt: ICVX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ICVX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ICVX has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 51.6% each year.


Discover healthy companies